Medical marketing news, white papers, reports, and events from PharmaLeaders. New content daily, on our website and delivered right to your inbox.
House drops CSRs, reinsurance from spending deal A measure to fund reinsurance and cost-sharing reductions has stalled after months of political wrangling as U.S. House of Representatives lawmakers scramble to agree on text for the mega-spending bill that was expected to drop early Monday evening. Republican congressmen Monday night blamed Democrats for the breakdown of negotiations on healthcare provisions in the spending omnibus ... Read More
Trump calls for death penalty for drug traffickers President Donald Trump on Monday said he believes the impact of the opioid abuse epidemic can be curbed by cutting opioid prescriptions by a third over the next three years. He also called for the death penalty for large-scale drug traffickers. The president’s “Initiative to Stop Opioid Abuse” calls for more aggressively prosecuting drug traffickers who ... Read More
MedPAC: Hospitals' Medicare margins continue to drop The Medicare Payment Advisory Commission has found that hospitals’ Medicare margins continue to plummet this year, sparking concerns about seniors’ access to care in the future. Hospitals’ aggregate Medicare margin was negative 9.6% in 2016, compared to negative 5.3% in 2009, according to MedPAC’s March 15 report to Congress. Not-for-profit hospitals had the lowest margins that ... Read More
Banner Health under federal investigation after 2016 cyberattack The federal government is investigating Banner Health’s information technology security following the massive 2016 cyberattack potentially affecting 3.7 million patients, the health system revealed in its 2017 financial report released Monday. HHS’ Office for Civil Rights may fine the Phoenix-based not-for-profit health system upon completion of its ongoing investigation, the system noted in its report. Banner ... Read More
Pediatric Gene Therapy The European approvals of Glybera® in 2012 and Strimvelis® in 2016 seem likely to be the vanguard of the therapeutic revolution heralded by the decoding of the human genome. Both of these treatments originated from academic centers of excellence and became the subjects of agreements with pharmaceutical companies (Uniqure/Chiesi and GSK, respectively) with the experience ... Read More
The Great DTC Shake-Up Patient perspectives on direct-to-consumer advertising This in-depth eyeforpharma whitepaper, which we developed with Health Perspectives Group explores the evolving role of DTC advertising with direct feedback from patient’s – including exclusive results from the recent “DTC Attitudes, Behaviours and Preferences” patient study conducted by Health Stories Project – Insights, (HSPi). Read More